1. USD

    74.30

    Today's change

    0.03 / +0.04%

    1 year change

    +24.25%

    As of May 22 2015 21:01 BST. Data delayed by at least 15 minutes.

Search for Eli Lilly & Co and
  1. April 29, 2015

    Takeda to pay $2.7bn to settle Actos cancer claims

    In one of the largest product liability settlements to date, Takeda Pharmaceutical has agreed to pay $2.7bn over claims that...

  2. April 5, 2015

    UK reprieve for three cancer drugs

    Three cancer drugs that were supposed to be removed from the National Health Service on cost grounds have been granted a...

Special Reports

  1. Special Report: Boldness in Business 2012

    Seven success stories are honoured in this year’s awards...
  2. Combating Diabetes

    Urbanisation, poor diet and failure to exercise have led to record levels of obesity, ...
Search more Special Reports on this topic.

  1. March 27, 2015

    Insulin: moving the needle

    It has been a sweet run. The biggest companies in the insulin business — Sanofi, Novo Nordisk, and Eli Lilly — have seen...

  2. March 26, 2015

    Indiana signs ‘religious freedom’ bill

    Indiana Governor Mike Pence has signed a bill that would allow businesses to refuse service to gay and lesbian patrons on...

  3. March 20, 2015

    Biogen’s Alzheimer’s drug shows early promise

    An experimental Alzheimer’s drug being developed by a US biotech group has offered hope that scientists may be closer to a...

  4. March 17, 2015

    Dementia research boosted by $100m venture capital fund

    Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

  5. February 24, 2015

    Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

    The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of possible...

  6. February 2, 2015

    Big pharmaceuticals groups faces biosimilars challenge

    Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

  7. December 11, 2014

    Broker’s upgrade boosts Eli Lilly shares

    Eli Lilly shares were buoyed by a brokerage upgrade on Thursday as Morgan Stanley analysts gained confidence over the...

  8. November 13, 2014

    Spread of city life destroys myth of diabetes as a western illness

    Which country has the most diabetics? The US seems the obvious candidate given its high rate of obesity – the main cause of...

  9. November 13, 2014

    Diabetes researchers find hope in link with dementia

    From his office at the Hammersmith Hospital in west London, Dr Paul Edison has begun the search for patients to participate...

  10. September 16, 2014

    AstraZeneca and Eli Lilly to unite for Alzheimer’s drug challenge

    AstraZeneca has struck a deal to jointly develop a treatment for Alzheimer’s disease with Eli Lilly of the US in a...

  11. September 16, 2014

    AstraZeneca swallows bittersweet pill with Eli Lilly Alzheimer’s deal

    Consciousness, the lens through which humans perceive the world, is ill-adapted for perceiving itself. The paradox is...

  12. September 15, 2014

    Lessons in failure from the error management gurus

    How do, and how should, businesses handle failure? Employers often talk about empowering people to take risks and learn from...

  13. August 25, 2014

    Chi-Med draws on the past for the future

    Hutchison China MediTech represents the past and the future of China’s pharmaceuticals industry. Much of its revenues come...

  14. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  15. June 12, 2014

    Taxing time ahead as offshore rules come under more scrutiny

    ‘Golden age’ for offshore cash The OECD called it “the golden age” of tax planning: a period in which multinational...

  16. June 8, 2014

    Japanese drugmakers sit out global M&A party

    Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

  17. May 7, 2014

    Pharma and Pfizer’s reputations on the line

    The proportion of UK cancer patients who survive 10 years after diagnosis rose from 25 per cent in the 1970s to 50 per cent...

  18. April 22, 2014

    Eli Lilly: animal spirits

    Eli Lilly has nothing if not momentum. Over six months, the drugmaker’s shares have returned 23 per cent, among the best of...

  19. April 22, 2014

    Eli Lilly: momentum and mean reversion

    Eli Lilly The investment universe has a Zoroastrian structure. The battle is between momentum and mean reversion. Stocks...

  20. April 22, 2014

    Novartis buys GSK business for up to $16bn in restructuring

    Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of...

  21. April 11, 2014

    Big pharma: Storehouse of trouble

    Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts...

  22. April 8, 2014

    Takeda and Eli Lilly fall foul of  jury in Actos trial

    For Mark Lanier, it was the biggest victory of his career as a plaintiff’s lawyer: a $9bn award for punitive damages against...

  23. April 8, 2014

    Takeda: a fine mess

    It’s a big, scary number. A US court has hit the Japanese drug company Takeda with a $6bn penalty after finding that it...

  24. FT Alphaville

    April 8, 2014

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE David revisits the €1,000,000,000,000 question, what will the ECB do? Dan notes the...

  25. April 8, 2014

    Takeda ordered to pay record $6bn over diabetes drug claim

    A US jury has hit two drug companies with a record $9bn fine for hiding an alleged link between a best-selling diabetes...

  26. February 19, 2014

    Eli Lilly jumps after cancer drug trial

    Shares in Eli Lilly climbed after the US pharmaceuticals group said a study of a lung cancer treatment increased survival...

  27. December 26, 2013

    Ethics: End of the hard sell?

    When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through...

  28. November 14, 2013

    Drug manufacturers seek to expand the range of treatments

    Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

  29. October 28, 2013

    Merck falls after miss on revenue

    Merck shares moved lower but the S&P500 touched another record high as company earnings were in focus. The health and...

  30. September 26, 2013

    Multinationals beach tax bills in Spanish shells

    A rented office overlooking a dusty rail track near Madrid’s airport was until recently the workplace of what would appear...

  31. September 26, 2013

    JC Penney rebounds on progress report

    JC Penney shares rebounded after a sharp slide in premarket trading, after the company said it was pleased with the progress...

  32. September 23, 2013

    Bribery claims infect drug companies’ dealings in China

    It began as a rumour on a Chinese social media site in July, but the impact has swiftly spread around the world: allegations...

  33. August 22, 2013

    Eli Lilly drawn into pharmaceutical corruption claims in China

    Eli Lilly became the latest western pharmaceutical group to be drawn into escalating allegations of corruption in China,...

  34. August 13, 2013

    Yum Brands hit by poor Chinese sales

    US markets continued a slow downward trend as Yum Brands fell on new sales data that showed its Chinese business continued...

  35. July 28, 2013

    Ireland’s ‘patent cliff’ poses problems for exit of bailout

    The metal reactors at Pfizer’s 200-acre manufacturing plant in Ringaskiddy that make the drug Viagra are not as busy as they...

  36. July 24, 2013

    China’s claims against GlaxoSmithKline echo SEC actions

    The allegations that Chinese authorities have made against GlaxoSmithKline’s operations resemble those levelled at other...

  37. July 24, 2013

    Apple rises above mixed US markets

    Well-received earnings from Apple boosted shares in the iPhone maker, helping the Nasdaq to post a slight increase while the...

  38. July 18, 2013

    Belgian pharma group in China probe

    UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

Search for Eli Lilly & Co and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Eli Lilly's John Lechleiter says pharma must reach out to inn...
    June 15, 2012

    Eli Lilly's John Lechleiter says pharma must reach out ...